BACKGROUND AND OBJECTIVES: Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence. METHODS: In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible. RESULTS: Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18-58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living. DISCUSSION: STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials.

From the Applied and Translational Neurogenomics Group University of Melbourne Royal Children's Hospital Florey and Murdoch Children's Research Institutes Melbourne Australia

Neurology. 2022 Jul 19;99(3):89-91. doi: 10.1212/WNL.0000000000200190. PubMed

Neurology. 2023 Jul 4;101(1):52. doi: 10.1212/WNL.0000000000201612. PubMed

Epilepsy Curr. 2022 Nov 28;23(1):20-22. doi: 10.1177/15357597221135963. PubMed

Zobrazit více v PubMed

Toonen RF, Verhage M. Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci. 2007;30(11):564-572. PubMed

Südhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323(5913):474-477. PubMed PMC

Ma C, Su L, Seven AB, Xu Y, Rizo J. Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release. Science. 2013;339(6118):421-425. PubMed PMC

Verhage M, Sørensen JB. SNAREopathies: diversity in mechanisms and symptoms. Neuron. 2020;107(1):22-37. PubMed

Verhage M, Maia AS, Plomp JJ, et al. . Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science. 2000;287(5454):864-869. PubMed

Santos TC, Wierda K, Broeke JH, Toonen RF, Verhage M. Early golgi abnormalities and neurodegeneration upon loss of presynaptic proteins Munc18-1, Syntaxin-1, or SNAP-25. J Neurosci. 2017;37(17):4525-4539. PubMed PMC

Saitsu H, Kato M, Mizuguchi T, et al. . De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40:782-788. PubMed

Otsuka M, Oguni H, Liang JS, et al. . STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study. Epilepsia. 2010;51(12):2449-2452. PubMed

Deprez L, Weckhuysen S, Holmgren P, et al. . Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology. 2010;75(13):1159-1165. PubMed

Hamdan FF, Piton A, Gauthier J, et al. . De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann Neurol. 2009;65(6):748-753. PubMed

Hamdan FF, Gauthier J, Dobrzeniecka S, et al. . Intellectual disability without epilepsy associated with STXBP1 disruption. Eur J Hum Genet. 2011;19(5):607-609. PubMed PMC

Stamberger H, Nikanorova M, Willemsen MH, et al. . STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology. 2016;86(10):954-962. PubMed

Saitsu H, Hoshino H, Kato M, et al. . Paternal mosaicism of an STXBP1 mutation in OS. Clin Genet. 2011;80(5):484-488. PubMed

Lammertse HCA, van Berkel AA, Iacomino M, et al. . Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain. 2020;143(2):441-451. PubMed PMC

Kovacevic J, Maroteaux G, Schut D, et al. . Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy. Brain. 2018;141(5):1350-1374. PubMed PMC

Guiberson NGL, Pineda A, Abramov D, et al. . Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones. Nat Commun. 2018;9(1):3986. PubMed PMC

Chai YJ, Sierecki E, Tomatis VM, et al. . Munc18-1 is a molecular chaperone for alpha-synuclein, controlling its self-replicating aggregation. J Cell Biol. 2016;214(6):705-718. PubMed PMC

Lopez-Rivera JA, Perez-Palma E, Symonds J, et al. . A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants. Brain. 2020;143(4):1099-1105. PubMed PMC

Mignot C, Moutard ML, Trouillard O, et al. . STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia. 2011;52(10):1820-1827. PubMed

Milh M, Villeneuve N, Chouchane M, et al. . Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia. 2011;52(10):1828-1834. PubMed

Di Meglio C, Lesca G, Villeneuve N, et al. . Epileptic patients with de novo STXBP1 mutations: key clinical features based on 24 cases. Epilepsia. 2015;56(12):1931-1940. PubMed

Gburek-Augustat J, Beck-Woedl S, Tzschach A, Bauer P, Schoening M, Riess A. Epilepsy is not a mandatory feature of STXBP1 associated ataxia-tremor-retardation syndrome. Eur J Paediatr Neurol. 2016;20(4):661-665. PubMed

Keogh MJ, Daud D, Pyle A, et al. . A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism. Neurogenetics. 2015;16(1):65-67. PubMed PMC

Richards S, Aziz N, Bale S, et al. . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. PubMed PMC

Kopanos C, Tsiolkas V, Kouris A, et al. . VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978-1980. PubMed PMC

Weckhuysen S, Holmgren P, Hendrickx R, et al. . Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia. 2013;54(5):e74-e80. PubMed

Muir AM, Myers CT, Nguyen NT, et al. . Genetic heterogeneity in infantile spasms. Epilepsy Res. 2019;156:106181. PubMed PMC

Boutry-Kryza N, Labalme A, Ville D, et al. . Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. Eur J Med Genet. 2015;58(2):51-58. PubMed

Kim YO, Korff CM, Villaluz MM, et al. . Head stereotypies in STXBP1 encephalopathy. Dev Med Child Neurol. 2013;55(8):769-772. PubMed

Carvill GL, Weckhuysen S, McMahon JM, et al. . GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology. 2014;82(14):1245-1253. PubMed PMC

Graham HK, Harvey A, Rodda J, Nattrass GR, Pirpiris M. The Functional Mobility Scale (FMS). J Pediatr Orthop. 2004;24(5):514-520. PubMed

Fisher RS, Cross JH, French JA, et al. . Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530. PubMed

Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-319. PubMed

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Publishing; 2013.

Goetz CG, Tilley BC, Shaftman SR, et al. . Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-2170. PubMed

epilepsydiagnosis.org/seizure/epileptic-spasms-overview.html.

O'Brien S, Ng-Cordell E, Study DDD, Astle DE, Scerif G, Baker K. STXBP1-associated neurodevelopmental disorder: a comparative study of behavioural characteristics. J Neurodev Disord. 2019;11(1):17. PubMed PMC

Loussouarn A, Doummar D, Beaugendre Y, et al. . Tremor-like subcortical myoclonus in STXBP1 encephalopathy. Eur J Paediatr Neurol. 2021;34:62-66. PubMed